; (B) by striking 4.3% and inserting 5.1% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (25) Imidacloprid Heading 9902.05.97 is amended— (A) by amending the article description to read as follows: N-[1-[(6-Chloropyridin-3-yl)methyl]-4,5-dihydroimidazol- 2-yl]nitramide (Imidacloprid) (CAS No. 138261–41–3) (provided for in subheading 2933.39.27) ; (B) by striking 4.3% and inserting 5.4% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (26) 2- C yanopyridine Heading 9902.06.20 is amended— (A) by amending the article description to read as follows: 2-Cyanopyridine (2-Pyridinecarbonitrile) (CAS No. 100–70–9) (provided for in subheading 2933.39.91) ; (B) by striking 2.3% and inserting 3.2% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (27) Quinclorac Heading 9902.06.23 is amended— (A) by amending the article description to read as follows: 3,7-dichloroquinoline-8-carboxylic acid (Quinclorac) (CAS No. 84087–01–4) (provided for in subheading 2933.49.30) ; (B) by striking Free and inserting 3.1% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (28) Azoxystrobin Heading 9902.06.30 is amended— (A) by amending the article description to read as follows: Methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4- yl]oxy}phenyl)-3-methoxyacrylate (Azoxystrobin) (CAS No. 131860–33–8) (provided for in subheading 2933.59.15) ; (B) by striking 6.2% and inserting 5.9% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (29) DEDS Heading 9902.06.41 is amended— (A) by amending the article description to read as follows: 5-Ethoxy-2-[(5-ethoxy-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)disulfanyl]-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidine (CAS No. 166524–75–0) (provided for in subheading 2933.59.70) ; (B) by striking 0.6% and inserting 5%